173 related articles for article (PubMed ID: 25822852)
1. Discovery of Small Molecules for Up-Regulating the Translation of Antiamyloidogenic Secretase, a Disintegrin and Metalloproteinase 10 (ADAM10), by Binding to the G-Quadruplex-Forming Sequence in the 5' Untranslated Region (UTR) of Its mRNA.
Dai J; Liu ZQ; Wang XQ; Lin J; Yao PF; Huang SL; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
J Med Chem; 2015 May; 58(9):3875-91. PubMed ID: 25822852
[TBL] [Abstract][Full Text] [Related]
2. Translational repression of the disintegrin and metalloprotease ADAM10 by a stable G-quadruplex secondary structure in its 5'-untranslated region.
Lammich S; Kamp F; Wagner J; Nuscher B; Zilow S; Ludwig AK; Willem M; Haass C
J Biol Chem; 2011 Dec; 286(52):45063-72. PubMed ID: 22065584
[TBL] [Abstract][Full Text] [Related]
3. Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region.
Lammich S; Buell D; Zilow S; Ludwig AK; Nuscher B; Lichtenthaler SF; Prinzen C; Fahrenholz F; Haass C
J Biol Chem; 2010 May; 285(21):15753-60. PubMed ID: 20348102
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10).
Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z
J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882
[TBL] [Abstract][Full Text] [Related]
5. An unusually stable G-quadruplex within the 5'-UTR of the MT3 matrix metalloproteinase mRNA represses translation in eukaryotic cells.
Morris MJ; Basu S
Biochemistry; 2009 Jun; 48(23):5313-9. PubMed ID: 19397366
[TBL] [Abstract][Full Text] [Related]
6. Regulation of α-secretase ADAM10 expression and activity.
Endres K; Fahrenholz F
Exp Brain Res; 2012 Apr; 217(3-4):343-52. PubMed ID: 21969210
[TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of the alpha-secretase ADAM10--risk or reason for hope?
Endres K; Fahrenholz F
FEBS J; 2010 Apr; 277(7):1585-96. PubMed ID: 20136654
[TBL] [Abstract][Full Text] [Related]
9. ADAM10 expression and promoter haplotype in Alzheimer's disease.
Bekris LM; Lutz F; Li G; Galasko DR; Farlow MR; Quinn JF; Kaye JA; Leverenz JB; Tsuang DW; Montine TJ; Peskind ER; Yu CE
Neurobiol Aging; 2012 Sep; 33(9):2229.e1-2229.e9. PubMed ID: 22572541
[TBL] [Abstract][Full Text] [Related]
10. Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17.
Shukla M; Htoo HH; Wintachai P; Hernandez JF; Dubois C; Postina R; Xu H; Checler F; Smith DR; Govitrapong P; Vincent B
J Pineal Res; 2015 Mar; 58(2):151-65. PubMed ID: 25491598
[TBL] [Abstract][Full Text] [Related]
11. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K
FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480
[TBL] [Abstract][Full Text] [Related]
12. Retinoids as a perspective in treatment of Alzheimer's disease.
Fahrenholz F; Tippmann F; Endres K
Neurodegener Dis; 2010; 7(1-3):190-2. PubMed ID: 20224284
[TBL] [Abstract][Full Text] [Related]
13. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.
Parkin E; Harris B
J Neurochem; 2009 Mar; 108(6):1464-79. PubMed ID: 19183255
[TBL] [Abstract][Full Text] [Related]
14. Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease.
Laws SM; Eckart K; Friedrich P; Kurz A; Förstl H; Riemenschneider M
Neurobiol Aging; 2011 Mar; 32(3):541-3. PubMed ID: 19344981
[TBL] [Abstract][Full Text] [Related]
15. Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative alpha-secretases, ADAM10 and TACE, without altering their mRNA levels.
Marshall AJ; Rattray M; Vaughan PF
Brain Res; 2006 Jul; 1099(1):18-24. PubMed ID: 16762326
[TBL] [Abstract][Full Text] [Related]
16. Acitretin, an enhancer of alpha-secretase expression, crosses the blood-brain barrier and is not eliminated by P-glycoprotein.
Holthoewer D; Endres K; Schuck F; Hiemke C; Schmitt U; Fahrenholz F
Neurodegener Dis; 2012; 10(1-4):224-8. PubMed ID: 22301853
[TBL] [Abstract][Full Text] [Related]
17. Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo.
Endres K; Mitteregger G; Kojro E; Kretzschmar H; Fahrenholz F
Neurobiol Dis; 2009 Nov; 36(2):233-41. PubMed ID: 19632330
[TBL] [Abstract][Full Text] [Related]
18. The retinoic acid receptor agonist Am80 increases hippocampal ADAM10 in aged SAMP8 mice.
Kitaoka K; Shimizu N; Ono K; Chikahisa S; Nakagomi M; Shudo K; Ishimura K; Séi H; Yoshizaki K
Neuropharmacology; 2013 Sep; 72():58-65. PubMed ID: 23624141
[TBL] [Abstract][Full Text] [Related]
19. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
20. Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme.
Musumeci G; Magro G; Cardile V; Coco M; Marzagalli R; Castrogiovanni P; Imbesi R; Graziano AC; Barone F; Di Rosa M; Castorina S; Castorina A
Cell Tissue Res; 2015 Oct; 362(1):45-60. PubMed ID: 25948484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
